Advertisements
Feeds:
Posts
Comments

Posts Tagged ‘minipig’


Gene-editing startup raising $10M to expand staff
Nov 25, 2015

Reporter: Stephen J. Williams,Ph.D.

From the Mineapolis/St. Paul Journal

source from: http://www.bizjournals.com/twincities/news/2015/11/25/gene-editing-startup-raising-10m-to-expand-staff.html 

Katharine Grayson
Staff reporter
Minneapolis / St. Paul Business Journal

Recombinetics Inc. is seeking $10 million in funding as it ramps up sales of its genetically tweaked animals.
The St. Paul-based biotech company’s recent round has already brought in about about $2.8 million from friends and family, said Chief Operating Officer Kyle Dawley. Company officials hope to close out the round within the next two months and add about 10 employees to its staff of 25.

 

 

Recombinetics edits pigs' genes for biomedical research purposes

Recombinetics edits pigs’ genes for biomedical research purposes. Photo source: Simone Van Den Berg

Recombinetics uses gene-editing technology to tweak animals for the agribusiness and biomedical markets. It’s biomedical business centers around pigs, which the company modifies for research purposes. That side of the company’s business already generates revenue, Dawley said, though he declined to reveal sales figures.

The company focuses on pigs, touting them as better research subjects than mice when it comes to testing medical devices and drugs for use in humans.

“Pigs are — size-wise and genetically — a lot more like humans than rats and mice,” Dawley said.

One of Recombinetics’ long-term goals is grow human organs inside pigs.

The company aims to modify livestock for food consumption as well. One of its projects calls for creating hornless cattle by taking a gene from one breed and putting into another.

Recombinetics expects food ventures may get a boost from the Food and Drug Administration’s recent approval of a genetically engineered salmon called “AquAdvantage.” The fish grows faster than traditional salmon thanks to the introduction of trout genes.

Recombinetics has raised $15 million since its founding.

Katharine Grayson covers med tech, clean tech, technology, health care and venture capital.

 

See also Surrogen, Inc., which produces transgenic pigs for purpose of large animal models of disease.

Other posts on this Open Access Journal where I have discussed the utility of the minipig as a large animal model of disease include:

The SCID Pig: How Pigs are becoming a Great Alternate Model for Cancer Research

The SCID Pig II: Researchers Develop Another SCID Pig, And Another Great Model For Cancer Research

Advertisements

Read Full Post »